NanoViricides
NNVC
#10121
Rank
C$31 M
Marketcap
C$1.72
Share price
0.14%
Change (1 day)
-18.19%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): C-$0.93

According to NanoViricides's latest financial reports the company's current EPS (TTM) is C-$0.92. In 2024 the company made an earnings per share (EPS) of C-$0.96 an increase over its 2023 EPS that were of C-$1.02.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.93-3.48%
2024C-$0.96-5.41%
2023C-$1.025.71%
2022C-$0.96-13.58%
2021C-$1.11-66.11%
2020C-$3.291.7%
2019C-$3.23-10.98%
2018C-$3.63-22.35%
2017C-$4.68-10.53%
2016C-$5.23375%
2015C-$1.10-85.19%
2014C-$7.4342.11%
2013C-$5.2326.67%
2012C-$4.13-6.25%
2011C-$4.4014.28%
2010C-$3.85100%
2009C-$1.93-0%
2008C-$1.93-33.33%
2007C-$2.89-0%
2006C-$2.894445.07%
2005C-$0.06358

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
C-$0.06881-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$2.92-416.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$8.97-1,073.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.09-543.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.45-1,233.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$4.95-636.71%๐Ÿ‡ฌ๐Ÿ‡ง UK